Concepts (90)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pyruvaldehyde | 6 | 2023 | 21 | 1.940 |
Why?
|
| Free Radical Scavengers | 1 | 2020 | 216 | 0.670 |
Why?
|
| Glycolysis | 6 | 2020 | 826 | 0.460 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2020 | 1692 | 0.420 |
Why?
|
| Diabetes Complications | 1 | 2019 | 1361 | 0.400 |
Why?
|
| Oxidative Stress | 1 | 2019 | 3085 | 0.300 |
Why?
|
| Colorectal Neoplasms | 3 | 2020 | 6773 | 0.250 |
Why?
|
| Carnosine | 2 | 2020 | 11 | 0.220 |
Why?
|
| Stromal Cells | 2 | 2017 | 1355 | 0.200 |
Why?
|
| Stress, Physiological | 2 | 2020 | 1404 | 0.190 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2020 | 70 | 0.180 |
Why?
|
| Mice, Inbred NOD | 2 | 2020 | 1877 | 0.160 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2019 | 1634 | 0.150 |
Why?
|
| Mice, SCID | 2 | 2020 | 2716 | 0.150 |
Why?
|
| Glycosylation | 1 | 2020 | 1126 | 0.140 |
Why?
|
| Clone Cells | 1 | 2020 | 1692 | 0.140 |
Why?
|
| Cell Line, Tumor | 7 | 2023 | 16687 | 0.140 |
Why?
|
| Langerhans Cells | 1 | 2016 | 173 | 0.130 |
Why?
|
| Cell Proliferation | 4 | 2020 | 10480 | 0.130 |
Why?
|
| Mutation | 1 | 2020 | 29784 | 0.130 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2019 | 644 | 0.130 |
Why?
|
| Lymphocyte Count | 1 | 2017 | 793 | 0.120 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2019 | 849 | 0.120 |
Why?
|
| Lactoylglutathione Lyase | 3 | 2019 | 16 | 0.120 |
Why?
|
| Meta-Analysis as Topic | 1 | 2019 | 1344 | 0.120 |
Why?
|
| Enzyme Activation | 1 | 2020 | 3701 | 0.120 |
Why?
|
| Alphapapillomavirus | 1 | 2016 | 221 | 0.110 |
Why?
|
| Calcium-Binding Proteins | 1 | 2018 | 1080 | 0.110 |
Why?
|
| Neoplasms | 2 | 2019 | 21672 | 0.110 |
Why?
|
| Head and Neck Neoplasms | 2 | 2017 | 2732 | 0.110 |
Why?
|
| Muscle Proteins | 1 | 2018 | 1159 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 1525 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2020 | 2503 | 0.100 |
Why?
|
| Metabolome | 1 | 2017 | 895 | 0.100 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2017 | 4033 | 0.100 |
Why?
|
| Pancreatic Neoplasms | 2 | 2019 | 5257 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2020 | 2938 | 0.090 |
Why?
|
| Hyperglycemia | 1 | 2019 | 1372 | 0.090 |
Why?
|
| Cell Movement | 2 | 2019 | 5216 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2017 | 1613 | 0.090 |
Why?
|
| Up-Regulation | 1 | 2019 | 4217 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2023 | 8426 | 0.090 |
Why?
|
| DNA Methylation | 1 | 2023 | 4289 | 0.080 |
Why?
|
| Glucose | 1 | 2017 | 4396 | 0.070 |
Why?
|
| Mitochondria | 1 | 2018 | 3520 | 0.060 |
Why?
|
| Animals | 6 | 2020 | 168788 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 4252 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2018 | 7879 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2018 | 6352 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2019 | 3557 | 0.050 |
Why?
|
| Receptors, Vitronectin | 1 | 2019 | 52 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2017 | 10182 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 3505 | 0.040 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2019 | 73 | 0.040 |
Why?
|
| Smad1 Protein | 1 | 2019 | 81 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 18027 | 0.040 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2019 | 182 | 0.040 |
Why?
|
| Subcellular Fractions | 1 | 2019 | 547 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 57768 | 0.040 |
Why?
|
| Chick Embryo | 1 | 2019 | 982 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2018 | 480 | 0.030 |
Why?
|
| Humans | 11 | 2023 | 744220 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2019 | 627 | 0.030 |
Why?
|
| Chickens | 1 | 2017 | 865 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2019 | 10250 | 0.030 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2017 | 377 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 1655 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2019 | 1538 | 0.030 |
Why?
|
| Aged | 3 | 2020 | 163253 | 0.030 |
Why?
|
| Cell Death | 1 | 2017 | 1708 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2018 | 2025 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 20817 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2019 | 3001 | 0.020 |
Why?
|
| Middle Aged | 3 | 2020 | 213367 | 0.020 |
Why?
|
| Adult | 3 | 2020 | 214035 | 0.020 |
Why?
|
| Autophagy | 1 | 2018 | 1300 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 6313 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2017 | 2017 | 0.020 |
Why?
|
| Male | 3 | 2020 | 350027 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2018 | 2895 | 0.020 |
Why?
|
| Prognosis | 2 | 2017 | 29050 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2017 | 2940 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2017 | 40559 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 9438 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 11007 | 0.010 |
Why?
|
| Mice | 2 | 2019 | 81178 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2017 | 6274 | 0.010 |
Why?
|
| Phenotype | 1 | 2017 | 16365 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2019 | 23404 | 0.010 |
Why?
|
| Female | 3 | 2019 | 380197 | 0.010 |
Why?
|
Concepts
(90)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_